Veracyte (VCYT) Misses Q4 EPS by 4c, Revenues Beat; Offers 1Q Revenues Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Veracyte (VCYT) Misses Q4 EPS by 4c, Revenues Beat; Offers 1Q Revenues Guidance Above Consensus

Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results

February 17, 2021 4:05 PM EST

Fourth Quarter Revenue Increased 16% to $34.5 Million; Volume Grew 14% to 13,130 Tests

Decipher Acquisition to Expand Global Leadership in Cancer Genomic Diagnostics While Accelerating Growth

Conference Call and Webcast Today at 4:30 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq:... More